Literature DB >> 14614674

Vaccinations for the pediatric traveler.

Sheila M Mackell1.   

Abstract

The care of the traveling child has become more complex and specialized as vaccine developments and recommendations have evolved. Differences in the pediatric immune response and the rationale for vaccine use or omission at certain ages must be considered. Protecting children from travel-related disease involves updating routine childhood immunizations and appropriately administering itinerary-specific travel vaccines. Routine childhood vaccinations may need to be accelerated for young infants traveling before the standard primary vaccine series can be completed. Hepatitis A, hepatitis B, Japanese encephalitis, yellow fever, varicella, and tickborne encephalitis vaccinations have pediatric indications, side effects, and uses. This review will address vaccine considerations and current US recommendations particular to traveling children.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614674     DOI: 10.1086/379515

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

Review 1.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

2.  A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

Authors:  Anne Cathrine Vestrheim; Anders Moen; Wolfgang Egge-Jacobsen; Leon Reubsaet; Trine Grønhaug Halvorsen; Diane Bryant Bratlie; Berit Smestad Paulsen; Terje Einar Michaelsen
Journal:  Immun Inflamm Dis       Date:  2014-05-22

3.  Prevention of travel-related infectious diseases in families of internationally adopted children.

Authors:  Elizabeth D Barnett; Lin H Chen
Journal:  Pediatr Clin North Am       Date:  2005-10       Impact factor: 3.278

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.